Comparison of the Global Initiative for Asthma Guideline–based Asthma Control Measure and the Childhood Asthma Control Test in Evaluating Asthma Control in Children  by Yu, Hong-Ren et al.
©2010 Taiwan Pediatric Association
ORIGINAL ARTICLE
Pediatr Neonatol 2010;51(5):273−278
*Corresponding author. Division of Allergy, Immunology & Rheumatology, Chang Gung Memorial Hospital-Kaohsiung Medical 
Center, and Chang Gung University, 123 Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung County 833, Taiwan.
E-mail: yangkd@adm.cgmh.org.tw
Background: Reliable assessment of asthma control is essential for effective treat-
ment. While several validated tools for assessing asthma control in children are 
currently available, few studies have evaluated the correlations between different 
asthma control measures in children. This study aimed to determine the correlations 
between the Childhood Asthma Control Test (C-ACT) and the Global Initiative for 
Asthma (GINA) guideline−based asthma control measure (ACM) with lung function 
parameters in children with asthma.
Methods: Sixty-three children aged 6−11 years with mild-intermittent to severe-
persistent asthma were evaluated. They completed the C-ACT, the GINA guideline−
based assessment and lung function tests with the help of their caregivers.
Results: C-ACT scores and GINA guideline−based ACM were positively correlated. The 
average C-ACT scores for children with controlled, partly controlled and uncontrolled 
asthma according to the GINA guidelines were 24.4 ± 0.3, 22.8 ± 0.6 and 21.3 ± 1.0 
(mean ± SE), respectively. High C-ACT scores were also noted in children with 
uncontrolled asthma based on the GINA guidelines. The GINA guideline−based ACM 
was correlated with spot spirometry parameters (forced vital capacity, forced 
expiratory volume in 1 second, and maximal mid-expiratory flow). Conversely, the 
C-ACT score was not correlated with these spirometry parameters.
Conclusions: The C-ACT may overestimate asthma control in certain circumstances. 
For children with poorly controlled asthma or poor symptom perception, more 
frequent visits and serial pulmonary function tests are recommended.
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1.  Introduction
The 2002 Global Initiative for Asthma (GINA) guide-
lines subdivided asthma severity into four categories 
(i.e., mild-intermittent, mild-persistent, moderate-
persistent, and severe-persistent) according to levels 
of symptoms and airflow limitation and variability.1 
However, treatment endpoints are not quantitatively 
defined. By aiming for a defined level of good con-
trol, the level of control is considered a better ap-
proach. Asthma control can be defined in a variety 
of ways. Meanwhile, since 2006, the revised GINA 
guidelines emphasize that treatment decisions should 
be based on achieving and maintaining asthma con-
trol, considering the symptoms present, degree of 
activity limitation, use of rescue bronchodilators, 
and lung function.2
Reliable and valid assessment of asthma control 
is essential for effective treatment of asthma. Sev-
eral validated and promising tools for asthma con-
trol assessment in children are currently available 
including the Childhood Asthma Control Test (C-ACT) 
for children aged 4−11 years old, the Asthma Con-
trol Test (ACT) for adolescents and young adults aged 
≥ 12 years old, and the GINA guideline−based assess-
ment of asthma control.2,3 All of these approaches 
are applicable in various clinical situations. Fur-
thermore, when translated into Chinese, the C-ACT 
remained reliable, valid and responsive.4 Ideally, 
new assessments should give more information on 
the condition of asthma control not provided by 
the currently available tools.
To date, no studies have determined the corre-
lations between different tools that assess asthma 
control in children. Therefore, this study was per-
formed to determine the correlations between the 
C-ACT and GINA guideline−based asthma control 
measure (ACM) with spot spirometry function para-
meters in children aged < 12 years old with asthma.
2.  Materials and Methods
This retrospective study evaluated asthmatic chil-
dren aged 6−11 years who completed the Chinese 
version of the C-ACT, the GINA guideline−based ACM, 
and bronchodilator tests on the same day in one visit. 
Between October and December 2007, 63 children 
with mild-intermittent to severe-persistent asthma 
who consecutively attended the outpatient de-
partment of the Chang Gung Memorial Hospital-
Kaohsiung Medical Center, Taiwan, were included. 
Their basic characteristics and medications were 
reviewed. All children included in this study had a 
history of asthma for ≥ 1 year and were provided with 
regular treatment according to GINA guidelines. 
Patients younger than 6 years old were excluded. The 
Institutional Review Board of Chang Gung Chil dren’s 
Hospital at Kaohsiung approved the study protocol.
Asthma severity was assessed according to the 
National Heart, Lung and Blood Institute guidelines 
and GINA guidelines.1,2,5 All of the children had 
allergies/sensitivities to at least one of the common 
allergens in Taiwan, and was determined by specific 
immunoglobulin E (IgE) measurement with the Phar-
macia Cap System (Phadia AB, Uppsala, Sweden) as 
described previously.6 Spirometry was measured 
using the Jaeger MasterScreen Spirometry system 
(Jaeger Co., Wurzburg, Germany) according to the 
American Thoracic Society guidelines.7 Standard 
spirometric measures included forced vital capacity 
(FVC), forced expiratory volume in 1 second (FEV1), 
peak expiratory flow (PEF), and maximal mid-
expiratory flow [MMEF; forced expiratory flow be-
tween 25−75% of vital capacity (FEF25−75%)].
Airway responsiveness to a bronchodilator was 
assessed measuring lung function 15 minutes after 
terbutaline inhalation (2 mg terbutaline diluted in 
normal saline to 2.5 mL). Spirometric measures in 
childhood were converted to percentages of the pre-
dicted value of normative values for non-asthmatic 
subjects.8 Changes in the percentage of predicted 
FEV1, FVC, and PEF values were derived by sub-
tracting the baseline percent predicted values and 
dividing them by the baseline percent predicted 
value.
2.1.  Statistical analysis
Statistical comparisons were made using the 
Wilcoxon rank sum test or Kruskal Wallis test, as 
appropriate. The sample size was initially set at 
60, based on the study power of 0.8, effect size of 
0.20 and a two-sided significance level of 0.05. We 
finally included 63 asthma children for this study. 
Correlations were determined using Spearman’s rank 
correlation test. A p value < 0.05 was regarded as 
statistically significant. All statistical tests were per-
formed using SPSS 12.0 (SPSS Inc., Chicago, IL, USA).
3.  Results
3.1.  Participant characteristics
Sixty-three children (43 boys and 20 girls) aged 
6−11 years (mean ± SD, 8.3 ± 1.7 years) were included. 
Asthma severity was based on the 2002 GINA guide-
lines. Of the 63 children, 8 had mild-intermittent 
asthma, 28 had mild-persistent asthma, 20 had 
moderate-persistent asthma, and 7 had severe-
persistent asthma. Although total IgE levels were 
higher in children with moderate-persistent and 
severe-persistent asthma, there were no statistical 
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differences in sex, age, total IgE, and specific IgE to 
house dust mites among these four groups (Table 1).
3.2.  Correlations between C-ACT scores and 
GINA guideline-based ACM groupings
As shown in Figure 1, C-ACT scores were signifi-
cantly correlated with the GINA guideline−based 
ACM groupings (r = −0.464, p < 0.001). According to 
the GINA guidelines, the controlled group had higher 
C-ACT scores (mean ± SE, 24.4 ± 0.3) than the partly 
controlled (22.8 ± 0.6) and uncontrolled (21.3 ± 1.0) 
groups. Interestingly, the mean C-ACT score was > 20, 
even in the uncontrolled group.
3.3.  GINA guideline-based ACM but not C-ACT 
correlated with spot prebronchodilator 
spirometry parameters
Correlations between C-ACT scores and the 
GINA guideline−based ACM with spot spirometry 
parameters were analyzed. As shown in Table 2, 
there were no differences in any spot spirometry 
parameter between the two C-ACT groups, including 
FEV1, FVC, FEV1/FVC, PEF, or MMEF values (expressed 
in percentage of predicted values). However, there 
was a significant difference in FEV1, FVC, PEF and 
MMEF between the controlled and uncontrolled 
groups as defined the GINA guideline−based ACM. 
There was also a significant difference in FEV1 and 
FVC between the partially controlled and uncon-
trolled groups.
When the C-ACT score was analyzed as a con-
tinuous variable and correlation analysis between 
C-ACT scores and prebronchodilator spirometric para-
meters were performed, there were significant 
correlations between prebronchodilator FEV1, FVC, 
PEF, and MMEF values (expressed in percentage of 
predicted values) and the GINA guideline−based 
ACM, but not with C-ACT scores (Table 3). Patients 
with poor asthma control showed poor lung func-
tion results.
3.4.  Neither the C-ACT scores nor GINA 
guideline-based ACM reflected airway 
reversibility
Airway responsiveness to bronchodilators is an im-
portant characteristic of asthma. As shown in Table 3, 
C-ACT scores and the GINA guideline−based ACM were 
not significantly correlated with airway responsive-
ness to bronchodilators presented as changes in per-
cent of predicted FEV1, FVC and PEF derived from 
the postbronchodilator test. Thus neither the C-ACT 
scores nor the GINA guideline−based ACM reflected 
airway responsiveness to bronchodilators.
4.  Discussion
Asthma is a heavy burden for sufferers, their fami-
lies and society, particularly for people with severe 
disease.9 The management goals in the GINA guide-
lines include optimal asthma control (without symp-
toms, acute exacerbation or daily activity limitations) 
and undisturbed sleep. Assessment of asthma control 
Table 1  Baseline characteristics of children according to Global Initiative for Asthma (GINA) severity grouping
GINA severity Mild-intermittent Mild-persistent Moderate-persistent Severe-persistent p
No. 8 (12.7%) 28 (44.4%) 20 (31.7%) 7 (11.1%)
Sex (M/F) 7/1 20/8 14/6 2/5 0.085
Age (mean ± SD)  8.0 ± 0.7  8.3 ± 0.3 8.6 ± 0.4 8.2 ± 0.5 0.893
IgE (IU)(mean ± SE) 345.6 ± 84.2 367.1 ± 55.3 768.0 ± 168.7 733.9 ± 340.2 0.080
Der p (class)  4.2 ± 1.0  4.1 ± 0.2 3.9 ± 0.4 4.2 ± 0.7 0.815
Der f (class)  3.8 ± 1.0  3.6 ± 0.3 3.7 ± 0.4 4.4 ± 0.5 0.726
IgE = Immunoglobulin E; Der p = Dermatophagoides pteronyssinus; Der f = Dermatophagoides farinae.
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Figure 1 Childhood Asthma Control Test (C-ACT) scores 
significantly correlated with GINA guideline−based asthma 
control measure groupings. The controlled group had 
higher C-ACT scores than the partly controlled and the 
uncontrolled groups. Significant differences are based 
on post hoc analysis. Data are presented as mean ± SE.
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is essential for effective management and assess-
ment of childhood asthma control and should in-
volve the children, their caregivers and physicians, 
and should occur in the clinic and at home. The 
GINA guideline−based ACM recommends question-
ing patients about the situation in the week prior to 
the consultation. Lung function parameters should 
also be included. However, the C-ACT asks the chil-
dren about the present situation without reference 
to the previous period, while the parents are asked 
about asthma control over the last 4 weeks.
The C-ACT is composed of seven items and is com-
pleted by the child and the caregiver. The scores 
of each item are summed into a total score (0−27), 
with lower scores indicating poorer control, and 
a score of < 20 indicating inadequately controlled 
asthma.3
This study analyzed the correlations between 
C-ACT scores and the GINA guideline−based ACM 
with spot spirometry function parameters in chil-
dren aged < 12 years old with asthma. Children 
with asthma were divided according to their C-ACT 
Table 2  Correlations between spot spirometry parameters with Childhood Asthma Control Test (C-ACT) scores 
and the Global Initiative for Asthma (GINA) guideline−based asthma control measure*
C-ACT score (% predicted) < 20 ≥ 20 p
FEV1 80.2 ± 9.1 89.8 ± 3.1 0.35
FVC 82.7 ± 10.2 95.3 ± 2.4 0.28
FEV1/FVC 96.6 ± 2.8 96.2 ± 1.6 0.94
PEF 74.6 ± 8.5 90.3 ± 3.1 0.15
MMEF 60.8 ± 8.5 70.8 ± 4.0 0.43
GINA control grade  
Controlled Partly controlled Uncontrolled p
(% predicted)
FEV1 92.8 ± 4.9 91.2 ± 3.7 72.9 ± 6.6 0.013† 0.03‡
FVC 98.9 ± 3.6 95.9 ± 3.2 76.5 ± 6.1 0.009† 0.016‡
FEV1/FVC 97.5 ± 2.3 95.0 ± 2.1 95.7 ± 4.3
PEF 94.1 ± 3.7 87.6 ± 5.3 76.2 ± 7.2 0.02†
MMEF 79.1 ± 5.8 65.7 ± 5.3 54.6 ± 7.4 0.031†
*Data are presented as mean ± SE; †p < 0.05 for the controlled versus uncontrolled group; ‡p < 0.05 for the partly controlled versus 
uncontrolled group. FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; PEF = peak expiratory flow; MMEF = 
maximal mid-expiratory flow.
Table 3 Correlations between Childhood Asthma Control Test (C-ACT) scores and the Global Initiative for Asthma 
(GINA) guideline−based asthma control measure with prebronchodilator and postbronchodilator lung function 
parameters
Prebronchodilator test C-ACT score GINA control grade
(% predicted) r p r p
FEV1  0.154  0.228 −0.288 0.022*
FVC  0.349  0.244 −0.288 0.022*
FEV1/FVC −0.092  0.472 −0.008 0.950
PEF  0.186 −0.271  0.145 0.031*
MMEF −0.002  0.986 −0.291 0.021*
Postbronchodilator C-ACT score GINA control grade
(% change) r p r p
FEV1  0.095 0.457  0.005 0.968
FVC −0.004 0.975  0.183 0.151
FEV1/FVC  0.052 0.687 −0.199 0.122
PEF  0.059 0.646 −0.033 0.797
MMEF −0.005 0.971  0.033 0.800
*p < 0.05. FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; PEF = peak expiratory flow; MMEF = maximal 
mid-expiratory flow.
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scores with C-ACT score of ≥ 20 indicating adequate 
control, while the others who scored 19 or less had 
inadequate control. Because C-ACT was developed 
for use in the clinics and at home, lung function 
is not assessed. Our analyses showed a significant 
correlation between C-ACT scores and the GINA 
guideline−based ACM, which suggests that both tools 
are useful for monitoring childhood asthma control 
in many conditions. However, in this study, 6 of the 
12 children with uncontrolled asthma according to 
the GINA guidelines visited the doctor for asthma 
exacerbation rather than as part of a regular follow-
up. When asked to complete the questionnaires, 
these patients and their caregivers presented higher 
C-ACT scores, but worse pulmonary function test 
(PFT) and the GINA guideline−based ACM results. 
This explains the high C-ACT scores among children 
with uncontrolled asthma (mean ± SE, 21.3 ± 1.0) in 
this series. The difference in evaluation intervals of 
these two tests and the poor symptom perception 
of some children might also contribute to these 
findings.10 Some simple and clear questions might 
be helpful to identify children with poor symptom 
perception.
PFT is a reliable test for evaluating small airway 
obstruction.11 Forced expiratory techniques are re-
liable for use in most children as young as 5−6 years 
of age.12 FEV1, FEV1/FVC and MMEF all relate well to 
asthma severity and are considered sensitive mark-
ers to predict airway obstruction.13,14 Dissociation 
of symptom reports with the degree of airflow ob-
struction have been noted and form part of written 
management plans, with pulmonary function mon-
itoring to improve asthma control.14,15 PFT results 
have reportedly changed management decisions in 
15% of visits.2 Thus it is recommended that PFT be 
performed at each visit to improve asthma control 
and identify patients at risk for progressive loss of 
lung function.14
Clinical decisions on asthma therapy should be 
based on all of the patient’s clinical symptoms, in 
addition to physical examination and PFT parameters. 
For convenience, PFT parameters are not included 
as an evaluation item in the C-ACT. This explains 
the relative correlation between PFT parameters 
and the GINA guideline−based ACM. However, the 
number of children was limited in our study, and 
C-ACT scores were still significantly correlated with 
the GINA guideline−based ACM. More studies are 
needed to evaluate the relationships between dif-
ferent asthma control measures with biomarkers 
and the daily PEF record.
Bronchodilator responses can reflect airway re-
versibility and airway inflammation.16 It can also be a 
predicator of further lung function and the response 
to treatment.17 However, bronchial hyperreactiv-
ity is not a constant feature and may be influenced 
by treatment in individual patients. With postbron-
chodilator test data, neither the C-ACT nor the GINA 
guideline−based ACM reflected the airway respon-
siveness to bronchodilation. The poor correlation 
between bronchodilator responses with clinical man-
ifestations corroborates the multi-faceted charac-
teristics of asthma.
5.  Conclusions
In conclusion, C-ACT scores and the GINA guideline−
based ACM are significantly correlated; both are re-
liable tools for monitoring childhood asthma control. 
However, only the GINA guideline−based ACM cor-
relates with spirometry parameters. In some condi-
tions, C-ACT scores may overestimate asthma control. 
PFT tests can provide complementary information 
about different aspects of asthma control. For chil-
dren with poorly controlled asthma or poor symptom 
perception, more frequent visits with serial pulmo-
nary function tests are recommended.
Footnote
The Global Initiative for Asthma guideline−based 
asthma control measure is available at http://www.
ginasthma.com. The Childhood Asthma Control Test is 
available at http://www.asthmacontrol.com/pdf/
BiChildENG.pdf.
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